Patients' own autoantibodies may hold key to boosting cancer immunotherapy response
A new study has revealed that autoantibodies—immune proteins traditionally associated with autoimmune disease—may profoundly influence how cancer patients respond to immunotherapy.
Jul 23, 2025
0
72









